Press release
Antibody-drug Conjugates Market 2024 Size, Industry Vertical, and Regional Forecast to 2030| ImmunoGen, Seattle Genetics, Roche, Takeda
LOS ANGELES, United States: The report named, "Global Antibody-drug Conjugates Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Antibody-drug Conjugates market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy instrument for the market participants to develop effective strategies with an aim to reinforce their market positions. This report offers pin-point analysis of the changing dynamics and emerging trends in the global Antibody-drug Conjugates market. Additionally, it provides a futuristic perspective on various factors that are likely to boost the global Antibody-drug Conjugates market growth in the years to come. Besides, authors of the report have shed light on the factors that may hamper the growth of the global Antibody-drug Conjugates market.According To Our Latest Report, The Global Market For Antibody-Drug Conjugates Should Grow From US$ 2831.3 Million In 2023 To US$ 3919.8 Million By 2030, With A CAGR Of 4.7% For The Period Of 2024-2030.
Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/pharma-healthcare-antibody-drug-conjugates-global-and-india-market-share-and-ranking-sales-production-and-demand-forecast-2024-2030
Competition is a major subject in any market research analysis. With the help of the competitive analysis provided in the report, players can easily study key strategies adopted by leading players of the global Antibody-drug Conjugates market. They will also be able to plan counterstrategies to gain a competitive advantage in the global Antibody-drug Conjugates market. Major as well as emerging players of the global Antibody-drug Conjugates market are closely studied taking into consideration their market share, production, revenue, sales growth, gross margin, product portfolio, and other significant factors. This will help players to become familiar with the moves of their toughest competitors in the global Antibody-drug Conjugates market. The report is just the right tool that players need to strengthen their position in the global Antibody-drug Conjugates market. It is also the perfect resource that will help players to sustain their lead or achieve a competitive position in the global Antibody-drug Conjugates market.
Key Players Mentioned in the Global Antibody-drug Conjugates Market Research Report: ImmunoGen, Seattle Genetics, Roche, Takeda
The segmental analysis included in the report helps manufacturers, companies, and stakeholders to identify key growth pockets in a market as competitive as the global Antibody-drug Conjugates market. Readers of the report will gain sound understanding of different factors helping the most lucrative segments of the global Antibody-drug Conjugates market to grow. With separate analysis of product type and application segments, the report attempts to unveil rewarding prospects available in the global Antibody-drug Conjugates market and how players can take advantage of them in the coming years.
Global Antibody-drug Conjugates Market by Type: Adcetris, Kadcyla
Global Antibody-drug Conjugates Market by Application: Breast Cancer, Lymphoma
The geographical analysis of the global Antibody-drug Conjugates market provided in the report is just the right tool that competitors can use to discover untapped sales and business expansion opportunities in different regions and countries. Each regional and country-wise Antibody-drug Conjugates market considered for research and analysis has been thoroughly studied based on market share, future growth potential, CAGR, market size, and other important parameters. Every regional market has a different trend or not all regional markets are impacted by the same trend. Taking this into consideration, the analysts authoring the report have provided an exhaustive analysis of specific trends of each regional Antibody-drug Conjugates market.
Reasons to Buy the Report
(1) This in-depth and comprehensive research on the global Antibody-drug Conjugates market will help you improve your market research skills.
(2) Acquire a thorough understanding of current and future market conditions to devise strategies for overcoming obstacles and ensuring consistent growth.
(3) It provides an in-depth analysis of changing market trends, current and future technologies, and the various strategies used by global Antibody-drug Conjugates industry leaders.
(4) It provides advice and support to newcomers to the global Antibody-drug Conjugates market and actively assists existing businesses in increasing their market share.
(5) It sheds light on the plans of the industry's leading firms and market advancements in the global Antibody-drug Conjugates market.
Request for customization in Report:
Table of Content
"1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Global Antibody-drug Conjugates Outlook 2019 VS 2023 VS 2030
1.2.1 Global Antibody-drug Conjugates Sales in US$ Million for the Year 2019-2030
1.2.2 Global Antibody-drug Conjugates Sales for the Year 2019-2030
1.3 India Antibody-drug Conjugates Outlook 2019 VS 2023 VS 2030
1.3.1 India Antibody-drug Conjugates Sales in US$ Million for the Year 2019-2030
1.3.2 India Antibody-drug Conjugates Sales for the Year 2019-2030
1.4 Antibody-drug Conjugates Market Size, India VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of India Antibody-drug Conjugates in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Antibody-drug Conjugates Market Size, India VS Global, 2019 VS 2023 VS 2030
1.5 Antibody-drug Conjugates Market Dynamics
1.5.1 Antibody-drug Conjugates Industry Trends
1.5.2 Antibody-drug Conjugates Market Drivers
1.5.3 Antibody-drug Conjugates Market Challenges
1.5.4 Antibody-drug Conjugates Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global and India Production
2.1 Global Antibody-drug Conjugates Production (2019-2030)
2.2 India Antibody-drug Conjugates Market Size
2.2.1 India Antibody-drug Conjugates Production (2019-2030)
2.2.2India Antibody-drug Conjugates Import & Export (2019-2030)
2.3 Global Antibody-drug Conjugates Production by Region: 2019 VS 2023 VS 2030, Based on Production Site
2.4 Global Antibody-drug Conjugates Production by Region
2.4.1 Global Antibody-drug Conjugates Historic Production by Region (2019-2024)
2.4.2 Global Antibody-drug Conjugates Forecasted Production by Region (2025-2030)
2.4.3 Global Antibody-drug Conjugates Production Market Share by Region (2019-2030)
2.5 North America
2.6 Europe
2.7 Japan
3 Antibody-drug Conjugates by Type
3.1 Antibody-drug Conjugates Market Segment by Type
3.1.1 Adcetris
3.1.2 Kadcyla
3.2 Global Antibody-drug Conjugates Market Size by Type
3.2.1 Global Antibody-drug Conjugates Revenue, by Type (2019, 2023 & 2030)
3.2.2 Global Antibody-drug Conjugates Sales, by Type (2019, 2023 & 2030)
3.2.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3.3 India Antibody-drug Conjugates Market Size by Type
3.3.1 India Antibody-drug Conjugates Revenue, by Type (2019, 2023 & 2030)
3.3.2 India Antibody-drug Conjugates Sales, by Type (2019, 2023 & 2030)
3.3.3 India Antibody-drug Conjugates Average Selling Price (ASP) by Type (2019, 2023 & 2030)
4 Antibody-drug Conjugates by Application
4.1 Antibody-drug Conjugates Market Segment by Application
4.1.1 Breast Cancer
4.1.2 Lymphoma
4.2 Global Antibody-drug Conjugates Market Size by Application
4.2.1 Global Antibody-drug Conjugates Revenue, by Application (2019, 2023 & 2030)
4.2.2 Global Antibody-drug Conjugates Sales, by Application (2019, 2023 & 2030)
4.2.3 Global Antibody-drug Conjugates Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4.3 India Antibody-drug Conjugates Market Size by Application
4.3.1 India Antibody-drug Conjugates Revenue, by Application (2019, 2023 & 2030)
4.3.2 India Antibody-drug Conjugates Sales, by Application (2019, 2023 & 2030)
4.3.3 India Antibody-drug Conjugates Average Selling Price (ASP) by Application (2019, 2023 & 2030)
5 Global Antibody-drug Conjugates Sales by Company
5.1 Global Key Manufacturers of Antibody-drug Conjugates, Ranked by Revenue (2023)
5.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2019-2024)
5.3 Global Antibody-drug Conjugates Sales by Manufacturer (2019-2024)
5.4 Global Antibody-drug Conjugates Price by Manufacturer (2019-2024)
5.5 Global Antibody-drug Conjugates Concentration Ratio (CR)
5.5.1 Antibody-drug Conjugates Market Concentration Ratio (CR) (2019-2024)
5.5.2 Global Top 5 and Top 10 Largest Manufacturers of Antibody-drug Conjugates in 2023
5.5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.6 Global Key Manufacturers of Antibody-drug Conjugates, Manufacturing Base Distribution and Headquarters
5.7 Global Key Manufacturers of Antibody-drug Conjugates, Product Offered and Application
5.8 Global Key Manufacturers of Antibody-drug Conjugates, Date of Enter into This Industry
5.9 Manufacturers Mergers & Acquisitions, Expansion Plans
6 India Antibody-drug Conjugates Sales by Company
6.1 Key Players of Antibody-drug Conjugates in India, Ranked by Revenue (2023)
6.2 India Antibody-drug Conjugates Revenue by Players (2019-2024)
6.3 India Antibody-drug Conjugates Sales by Players (2019-2024)
7 Global Antibody-drug Conjugates Market Size by Region
7.1 Global Antibody-drug Conjugates Market Size by Region: 2019 VS 2023 VS 2030
7.2 Global Antibody-drug Conjugates Sales by Region (2019-2030)
7.2.1 Global Antibody-drug Conjugates Sales by Region: 2019-2024
7.2.2 Global Antibody-drug Conjugates Sales Forecast by Region (2025-2030)
7.3 Global Antibody-drug Conjugates Revenue by Region (2019-2030)
7.3.1 Global Antibody-drug Conjugates Revenue by Region: 2019-2024
7.3.2 Global Antibody-drug Conjugates Revenue by Region: 2025-2030
7.4 North America
7.5 Europe
7.6 China
7.7 Japan
7.8 India
7.9 Southeast Asia
7.10 Latin America and Middle East & Africa
8 Company Profiles
8.1 ImmunoGen
8.1.1 ImmunoGen Company Information
8.1.2 ImmunoGen Description and Business Overview
8.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2024)
8.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
8.1.5 ImmunoGen SWOT Analysis
8.1.6 ImmunoGen Recent Development
8.2 Seattle Genetics
8.2.1 Seattle Genetics Company Information
8.2.2 Seattle Genetics Description and Business Overview
8.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
8.2.5 Seattle Genetics SWOT Analysis
8.2.6 Seattle Genetics Recent Development
8.3 Roche
8.3.1 Roche Company Information
8.3.2 Roche Description and Business Overview
8.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Roche Antibody-drug Conjugates Products Offered
8.3.5 Roche SWOT Analysis
8.3.6 Roche Recent Development
8.4 Takeda
8.4.1 Takeda Company Information
8.4.2 Takeda Description and Business Overview
8.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Takeda Antibody-drug Conjugates Products Offered
8.4.5 Takeda SWOT Analysis
8.4.6 Takeda Recent Development
9 Industry Chain and Sales Channels Analysis
9.1 Antibody-drug Conjugates Industry Chain Analysis
9.2 Antibody-drug Conjugates Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 Antibody-drug Conjugates Production Mode & Process
9.4 Antibody-drug Conjugates Sales and Marketing
9.4.1 Antibody-drug Conjugates Sales Channels
9.4.2 Antibody-drug Conjugates Distributors
9.5 Antibody-drug Conjugates Customers
10 Research Findings and Conclusion
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Author Details
11.3 Disclaimer
Contact US
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909
ankit@qyresearch.com / enquiry@qyresearch.com
About Us:
QYResearch is a leading global market research and consulting company established in 2007. With over 16 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody-drug Conjugates Market 2024 Size, Industry Vertical, and Regional Forecast to 2030| ImmunoGen, Seattle Genetics, Roche, Takeda here
News-ID: 3480087 • Views: …
More Releases from QYResearch Inc.

Ultra-high Vacuum Electron Beam Evaporator (EBE) Market Forecast 2025-2031, Indu …
QY Research's latest publication, titled "Ultra-high Vacuum Electron Beam Evaporator (EBE) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", offers an insightful take on the drivers and restraints present in the market. The research study on the global Ultra-high Vacuum Electron Beam Evaporator (EBE) market equips you with detailed and accurate analysis that will help you to strengthen your market position. It provides latest updates and…

Aluminum Plastic Recycling Equipment Market 2025, Global Demand Surge, Technolog …
QY Research's latest publication, titled "Aluminum Plastic Recycling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", offers an insightful take on the drivers and restraints present in the market. The research study on the global Aluminum Plastic Recycling Equipment market equips you with detailed and accurate analysis that will help you to strengthen your market position. It provides latest updates and powerful insights about the…

Voltammeters Market 2025, Strategic Market Insights, Emerging Applications, and …
QY Research's latest publication, titled "Voltammeters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", offers an insightful take on the drivers and restraints present in the market. The research study on the global Voltammeters market equips you with detailed and accurate analysis that will help you to strengthen your market position. It provides latest updates and powerful insights about the Voltammeters industry so you could improve…

Associative Polyurethane Rheology Additives Market Trends, Growth Rate, Key Comp …
QY Research's latest publication, titled "Associative Polyurethane Rheology Additives - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", offers an insightful take on the drivers and restraints present in the market. The research study on the global Associative Polyurethane Rheology Additives market equips you with detailed and accurate analysis that will help you to strengthen your market position. It provides latest updates and powerful insights about the…
More Releases for Conjugates
Global Cancer Antibody Drug Conjugates Market
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions:
• Global Cancer Antibody Drug Conjugates Market: 2020 - 2030
• Global Cancer Antibody Drug Conjugates Market Opportunity > US$ 50 Billion By 2030
• Approved Cancer Antibody Drug Conjugates: 16 Drugs
• Approved Cancer Antibody Drug Conjugates Sales Insights, Patent, Dosage and Price Analysis
• Cancer Antibody Drug Conjugates In Clinical Trials: > 500 Drugs
• Cancer Antibody Drug Conjugates Clinical…
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
DLL3 Antibody-Drug Conjugates: Mechanisms and Efficacy
Antibody-drug conjugates (ADCs) represent a revolutionary approach in cancer treatment, combining the targeting capabilities of antibodies with the cytotoxic power of chemotherapy. DLL3 (Delta-Like Ligand 3) has emerged as a promising target for ADCs, particularly in the treatment of small cell lung cancer (SCLC) and other neuroendocrine tumors. This article explores the mechanisms and efficacy of DLL3 ADCs, shedding light on their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3 is a…
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook…
Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027.
Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,…
Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement…